Cardiac Disease Clinical Trial
— BraSIS-2Official title:
Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit: an Observational, Prospective, Multicenter Study
NCT number | NCT06154473 |
Other study ID # | 5350-22 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | September 1, 2023 |
Est. completion date | November 2024 |
The objective of this study is to investigate the incidence of death and early postoperative complications, identify potential risk factors, and examine the demographic characteristics of patients and epidemiology of cardiovascular procedures. Our hypothesis is that gaining a more comprehensive understanding of the characteristics of patients who undergo cardiac surgery has the potential to improve outcomes for this patient profile. Thus, information was sought regarding the patient characteristics, surgeries performed, anesthesia administered, incidence of intraoperative and postoperative complications, and risk factors associated with complication and mortality in the ICU. The main questions it aims to answer are: - Incidence of mortality or severe postoperative complications that occur within the first 3 postoperative days or until discharge from the ICU. - Risk factors associated with severe complications in patients who undergo cardiac surgery. - Characteristics of patients, anesthesia and surgical procedures performed - Incidence of severe intraoperative complications and moderate postoperative complications - Evaluate the influence of accumulated fluid balance on outcomes, mortality, and length of ICU stay. - Evaluate mortality in the ICU. - Describe the risk factors associated with mortality.
Status | Recruiting |
Enrollment | 500 |
Est. completion date | November 2024 |
Est. primary completion date | September 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patients (age 18 years or older). - Cardiac surgeries requiring postoperative care in the ICU. Exclusion Criteria: - Exclusive palliative care or advance directive expressing desire for limitation of life support (cardiopulmonary resuscitation, invasive mechanical ventilation, renal replacement therapy). - Moribund patient. - Surgery for implant of cardiac implantable electronic device (implantable cardioverter defibrillator, cardiac pacemaker). - Patients previously included in this study. |
Country | Name | City | State |
---|---|---|---|
Brazil | Hospital Israelita Albert Einstein | São Paulo |
Lead Sponsor | Collaborator |
---|---|
Hospital Israelita Albert Einstein |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mortality or severe postoperative complications within the first 3 postoperative days or until ICU discharge, whichever occurs first | Severe postoperative complications are: stroke, septic shock, unscheduled urgent or emergency surgical reoperation, cardiovascular complications, hematological complications, pulmonary complications, and renal complications | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days | |
Secondary | Evaluate the characteristics of the patients | Describe demographic characteristics of the patients | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days | |
Secondary | Describe the surgeries performed | Describe the type of surgeries performed. Description of the surgery as: emergency, urgent and elective surgery; open heart surgery or percutaneous cardiovascular surgery; valve repair (or replacement) and/or coronary artery bypass grafting | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days | |
Secondary | Describe the anesthesia performed | The following anesthesia modalities will be considered and collected: general anesthesia, combined general anesthesia (general anesthesia and neuroaxis block) and sedation | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days | |
Secondary | Evaluate the incidence of severe intraoperative complications | The following severe intraoperative complications will be considered and collected: bronchospasm or difficulty with respiratory support, failure to exit cardiopulmonary bypass (CPB), cardiac arrest with return of spontaneous circulation, and excessive blood transfusion (= 4 units of packed red blood cells) | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days | |
Secondary | Assess the incidence of other postoperative complications (not included in the primary endpoint) | The following postoperative complications will be considered and collect: cardiovascular; pulmonary; neurological, gastrointestinal and metabolic | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days | |
Secondary | Evaluate the influence of fluid balance on ICU mortality | Evaluate the influence of fluid balance on ICU mortality. Determine if the increase in fluid balance during the ICU stay is associated with the increase in ICU mortality. | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days | |
Secondary | Assess the length of stay in the ICU | Calculated from the date and time of admission and date and time of actual ICU discharge (discharge or death) | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days | |
Secondary | Evaluate the risk factors associated with ICU mortality | To construct a logistic regression model to identify risk factors associated with increased ICU mortality. | Within the first 3 postoperative days or until ICU discharge, whichever occurs first, assessed up to 3 postoperative days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05490303 -
HeartGuide: Preliminary Study
|
N/A | |
Completed |
NCT05070819 -
Atrial Natriuretic Peptide in Assessing Fluid Status
|
N/A | |
Not yet recruiting |
NCT04511403 -
Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
|
||
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Completed |
NCT02697760 -
The CZT Dynamic Myocardial Perfusion Imaging
|
||
Terminated |
NCT05157568 -
Pilot Randomized Clinical Trial of Live-streamed Cardiovascular Rehabilitation
|
N/A | |
Not yet recruiting |
NCT04160845 -
Non-invasive Forehead Skin Temperature in Cardiac Surgery
|
||
Completed |
NCT04500912 -
Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population
|
N/A | |
Not yet recruiting |
NCT06438159 -
Impact of Mindfulness-Based Stress Reduction Meditation Practice on Patients After Cardiac Rehabilitation.
|
N/A | |
Not yet recruiting |
NCT05877755 -
Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging
|
N/A | |
Completed |
NCT03394859 -
Electronic Medical Records and Genomics (eMERGE) Phase III
|
||
Recruiting |
NCT05055830 -
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
|
||
Recruiting |
NCT04374799 -
Heparin vs Placebo for Cardiac Catheterization
|
Phase 3 | |
Completed |
NCT03174106 -
Longterm Follow-up of Cardiac Patients With an Smartphone-Application
|
N/A | |
Recruiting |
NCT05531253 -
Respired Gases in Patients Post Cardiac Surgery
|
||
Recruiting |
NCT04609228 -
Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors
|
||
Recruiting |
NCT06149143 -
Cardiac Performance System Data Collection Study - Minnesota
|
||
Recruiting |
NCT05725655 -
Hot Water Immersion After Myocardial Infarction
|
N/A | |
Recruiting |
NCT06073509 -
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
|
||
Enrolling by invitation |
NCT04886934 -
Temporary Epicardial Pace Wire With Integrated Sensor for Continuous Postoperative Monitoring of Myocardial Function
|
N/A |